Indian pharma presents an appealing proposition. A strong talent pool, extensive technological and manufacturing competence, regulatory maturity, and a mature chemical industry, stated Sameer Hiremath,
There is an urgent need to eliminate unnecessary animal studies, and establish clear conditions for requiring comparative clinical trials for affordable biosimilars without compromising safety
Glenmark Pharmaceuticals is steering toward a sharper, innovation-driven future over the next four to five years, with a strategic focus on its novel drug portfolio
NEW DELHI: Several domestic drug companies are set to transform diabetes therapy by launching the blockbuster drug Empagliflozin at a fraction of the innovator’s price.Affordable
The drug is called bimagrumab. It was originally developed for rare muscle-wasting diseases, but in a trial involving people with obesity and type 2 diabetes,
largest pharmaceutical producers, each excelling in its unique strengths. India, famously dubbed the “Pharmacy of the World,” specializes in manufacturing vast quantities of generic drugs,
Microsoft has launched BioEmu, an artificial intelligence system designed to speed up the process of understanding how proteins behave in the human body, work that
Prozo has raised $20 million to date, with participation from investors such as Sixth Sense Ventures and Jafco Asia.Prozo, one of India’s fastest-scaling integrated supply